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Mucosal-associated invariant T (MAIT) cells are innate T lymphocytes
activated by bacteria that produce vitamin B2 metabolites. Mouse
models of infection have demonstrated a role for MAIT cells in anti-
microbial defense. However, proposed protective roles of MAIT cells
in human infections remain unproven and clinical conditions associ-
ated with selective absence of MAIT cells have not been identified.
We report that typhoidal and nontyphoidal Salmonella enterica
strains activate MAIT cells. However, S. Typhimurium sequence type
313 (ST313) lineage 2 strains, which are responsible for the burden of
multidrug-resistant nontyphoidal invasive disease in Africa, escape
MAIT cell recognition through overexpression of ribB. This bacterial
gene encodes the 4-dihydroxy-2-butanone-4-phosphate synthase en-
zyme of the riboflavin biosynthetic pathway. The MAIT cell-specific
phenotype did not extend to other innate lymphocytes. We propose
that ribB overexpression is an evolved trait that facilitates evasion
from immune recognition by MAIT cells and contributes to the inva-
sive pathogenesis of S. Typhimurium ST313 lineage 2.
Salmonella Typhimurium | sequence type 313 | ST313 |
invasive nontyphoidal Salmonella | MR1
The gram-negative bacterium Salmonella enterica spp. comprisesmany serovars which are closely related phylogenetically but
cause very different disease presentations and distinct immune
responses in immunocompetent hosts (1, 2). Infection by the hu-
man restricted Salmonella typhoidal serovars (S. Typhi and S.
Paratyphi) results in a severe systemic disease called enteric fever.
In contrast, nontyphoidal serovars originating from zoonotic res-
ervoirs such as S. Typhimurium and S. Enteritidis, cause self-
limiting diarrheal disease in healthy individuals (1–3). Multidrug
resistant S. Typhimurium strains of a distinct multilocus sequence
type 313 (ST313) recently emerged in sub-Saharan Africa. S.
Typhimurium ST313 is associated with invasive blood stream in-
fections in immunocompromised individuals and is distinct from
the S. Typhimurium strains that cause gastroenteritis globally.
Since it was first reported in 2009 (4), the S. Typhimurium
ST313 clade has become the major cause of invasive nontyphoidal
Salmonella (iNTS) disease in Africa (5, 6) and comprises two
subclade lineages (6), termed lineages 1 and 2. Bacteraemia by
iNTS causes an estimated 77,500 deaths annually worldwide (7),
primarily in Africa, among young children with recent malaria,
malarial anemia, or malnutrition and in adults afflicted with HIV,
among whom recurrent disease is also common (1, 5, 8–11). S.
Typhimurium ST313 isolates have rarely been reported outside of
Africa (4) and African ST313 blood isolates are genetically distinct
from rare diarrheal ST313 isolates found in the United Kingdom
(12) or Brazil (13). Genotypic and phenotypic analyses of several
clinical isolates of the two well-described ST313 lineages identified
signatures of metabolic adaptation and unique enteropathogenesis
in animal models, consistent with adaptation to invasive disease in
an immunocompromised human population (4, 14, 15).
B and T cell responses can mediate a protective role in mouse
models of Salmonella infection. B cells provide the first line of
defense at mucosal sites to restrain systemic dissemination, while
T cells are needed for Salmonella clearance (16–18). Cross-
reactive and serovar-specific MHC-restricted T cell responses
have been well characterized in humans (19–24). Salmonella can
also induce activation of non-MHC-restricted T cells, specifically
γδ T cells, invariant natural killer T cells (iNKTs), and mucosal-
associated invariant T (MAIT) cells (25–27), although their pro-
tective role remains undetermined.
Significance
Nontyphoidal Salmonella serotypes are a common cause of
self-limiting diarrhoeal illnesses in healthy adults. However,
recently, a highly invasive multidrug resistant Salmonella
Typhimurium sequence type 313 has emerged as a major cause
of morbidity and mortality in sub-Saharan Africa, particularly in
children and immunosuppressed individuals. In this paper we
describe escape from MAIT cell recognition as an additional
mechanism of immune evasion of S. Typhimurium ST313. As
MAIT cells represent an early defense mechanism against
pathogens at mucosal surfaces, and their frequency and func-
tion are altered in immunosuppressed individuals in sub-
Saharan Africa, harnessing their function may offer an impor-
tant therapeutic strategy to improve mucosal immunity.
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MR1-restricted MAIT cells comprise a highly conserved class
of semi-invariant T cells, bridging innate and adaptive immunity
(28). The MHC class I-like molecule MR1, bound to derivatives
of vitamin B2 intermediates, activates MAIT cells (29). This
process can drive antibacterial activity, in vitro and in vivo, and
correlates with the presence of the vitamin B2 biosynthetic
pathway in several commensal and pathogenic bacteria and
fungal species (reviewed in ref. 30). Similar to iNKT and γδ
T cells, MAIT can be activated by cytokines (IL-12, IL-18, type I
IFN) independently of their TCR engagement (31). The ability
of MAIT cells to recognize S. Typhimurium-infected targets (32)
prompted the identification, within bacterial supernatants, of the
potent MAIT cell agonists (lumazine and pyrimidines), deriva-
tives of the vitamin B2 intermediate 5-A-RU (29, 33). Following
intranasal infection with S. Typhimurium, murine MAIT cells
become activated and accumulate in the lungs (26). Human
challenge studies with typhoidal serovars (S. Typhi and S. Par-
atyphi A) also demonstrated sustained MAIT cell activation and
proliferation at peak of infection (34, 35).
While many commensal and pathogenic bacteria possess the
riboflavin biosynthetic pathway, the levels of resulting MAIT
stimulation varies (36, 37), perhaps reflecting the influence of
microenvironment on bacterial metabolism and antigen avail-
ability. The ability of MAIT cells to recognize and respond to
several isolates of the same pathogen may also vary depending
on metabolic differences between isolates (38).
We hypothesized that MAIT cells contributed to the cellular
response to Salmonella enterica serovars responsible for invasive
disease, and examined the ability of MAIT cells to recognize and
respond to different S. enterica serovars associated with invasive
disease in Africa. Here, we demonstrate that S. Typhimurium
ST313 lineage 2 isolates escape MAIT cell recognition through
overexpression of RibB, a bacterial enzyme of the riboflavin bio-
synthetic pathway. Our results suggest that MAIT cell immune
protection represents an important “evolutionary bottleneck” for
the pathogen.
Results
Identification of Cellular Responses to Multiple Salmonella enterica
subsp enterica Serovars. To identify potential differences in the re-
sponse of innate and adaptive T cells to distinct Salmonella path-
ovars, we focused on two pathovariants of S. Typhimurium that are
responsible for different types of human disease. S. Typhimurium
ST313 is associated with invasive disease among immunocompro-
mised individuals in Africa and a representative isolate is D23580
(STM-D23580). S. Typhimurium sequence type 19 (ST19) causes
noninvasive diarrheal infections in immunocompetent individuals
globally (a representative isolate is LT2, designated STM-LT2).
Peripheral blood mononuclear cells (PBMCs) isolated from healthy
donors were infected with both S. Typhimurium pathovariants, and
S. Typhi strain Ty2 (ST-Ty2) was used to represent a more distantly
related serovar that causes invasive disease in immunocompetent
individuals. Escherichia coli (E. coli) was included as unrelated
control. Upon infection, PBMCs were incubated overnight in the
presence of brefeldin A to permit intracellular cytokine accumu-
lation. T lymphocytes were stained with a panel of fluorescently
labeled antibodies to simultaneously identify different T cell
populations (MAIT, γδ, CD4, and CD8) and determine their
activation status (CD69) and cytokine production (IFN-γ and
TNF-α).
We first defined the heterogeneity of T cell responses to
Salmonella by performing an unsupervised clustering analysis on
all CD3+ T cells expressing the activation marker CD69 fol-
lowing overnight incubation with the Salmonella pathovariants.
Dimensionality reduction analysis by t-distributed stochastic
neighbor embedding (t-SNE) revealed 22 populations of CD3+
CD69+ T cells, some of which differed in frequency according to
the infecting Salmonella pathogen. Clusters were then annotated
and assigned to MAIT (identified as CD3+ Vα7.2+ CD161high),
γδ+, CD4+, or CD8+ T cell subsets based on the expression of
distinct phenotypic markers.
We discovered that a group of clusters of MAIT cells (clusters
6, 15, 18, and 21) was underrepresented among all CD69+ cells
upon infection with STM-D23580, compared with STM-LT2,
ST-Ty2, and E. coli (Fig. 1A). Next, we analyzed expression of
IFN-γ and TNF-α in CD69+ activated T cells. We determined
that the underrepresented clusters of CD69+ MAIT cells rep-
resented IFN-γ- and TNF-α-producing MAIT cells (Fig. 1B).
MAIT cells were next analyzed using uniform manifold ap-
proximation and projection (UMAP), a neighboring dimen-
sionality reduction technique that preserves embedding and
global distances better than t-SNE (39), and clearly defined the
trajectory of the distinct subpopulations of Salmonella-activated
MAIT cells (Fig. 1C). STM-LT2-stimulated MAIT cells clus-
tered close to MAIT cells stimulated with ST-Ty2 and E. coli,
which were characterized by elevated expression of CD69 and
the presence of single and double producers of TNF-α and IFN-
γ. In contrast, STM-D23580-stimulated MAIT cells clustered
closer to unstimulated cells, away from MAIT cells stimulated
with ST-Ty2 and E. coli (Fig. 1 D, Top Left). STM-D23580-
stimulated MAIT cells expressed low levels of CD69, with only a
small TNF-α-producing subpopulation and almost no IFN-γ
producing cells (Fig. 1D).
S. Typhimurium ST313 Lineage 2 Fails to Elicit MAIT Cell Activation in
Healthy and Susceptible Individuals. To validate our unsupervised
analysis, we infected PBMCs with the different Salmonella
strains at increasing multiplicity of infection (MOI) and then
assessed MAIT cell activation by flow cytometry. Infection by
STM-D23580 consistently induced limited MAIT cell responses
across a range of MOIs and in every healthy donor tested. In
comparison with STM-LT2, ST-Ty2, or E. coli, STM-D23580-
stimulated MAIT cells significantly expressed less CD69 and
produced less IFN-γ and TNF-α (Fig. 2 A–D). This effect was not
dependent on a selective loss of MAIT cells, as STM-D23580 did
not have a detrimental effect on MAIT cell viability (SI Appen-
dix, Fig. S1A). γδ T cells, a subset of innate T lymphocytes also
present in PBMCs, were strongly activated by STM-D23580,
indicating that the lack of activation is a phenomenon limited to
MAIT cells (Fig. 2 A and C).
In culture, Salmonella spp. secrete vitamin B2 intermediates
that can bind to MR1 on antigen-presenting cells (APCs), to
trigger MAIT cell activation (29). To examine whether STM-
D23580 secretes MAIT cell agonists, we collected supernatants
from single-colony cultures to stimulate PBMCs. Supernatants
from STM-LT2 and E. coli induced a dose-dependent produc-
tion of IFN-γ and TNF-α by MAIT cells, whereas STM-D23580
supernatants did not (SI Appendix, Fig. S1B).
To validate such findings, we assessed MAIT cell responses to
a broader selection of bacterial isolates, including two S. Typhi
strains (ST-Ty2 and ST-Quailes) and one S. Paratyphi A strain;
in addition two differently sourced stocks of STM-D23580 were
tested, to ensure that genuine sequence type 313 isolates were
being used. At two different MOIs, STM-D23580 elicited the
lowest levels of MAIT cell activation of the group (SI Appendix,
Fig. S1 C and D). In contrast, γδ T cell responses were com-
parable across all Salmonella pathovars (SI Appendix, Fig. S1
E and F).
We next determined whether the lack of MAIT cell activation
was caused by the entire S. Typhimurium ST313 clade or was a
unique characteristic of ST313 lineage 2 which is currently
causing most clinical disease in Africa (14). STM-D23580 and
additional isolates of ST313 lineage 2, were compared with
closely related isolates that were members of ST313 lineage 1 or
the UK ST313 group that is associated with gastroenteritis
(Fig. 2E). To examine MR1-independent MAIT cell activation,
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we used Enterococcus faecalis as a negative control as it lacks the
vitamin B2 biosynthetic pathway (29).
Remarkably, only the ST313 strains belonging to lineage 2,
such as D23580, D37712, and U60, failed to elicit MAIT cell
activation (Fig. 2 F and G). All other Salmonella ST313 lineages
tested (strains U2, U5, and D25248) triggered the same level of
MAIT cell responses as S. Typhimurium 4/74 (STM-4/74) (40), a
sequence type 19 strain that is closely related to STM-LT2 and is
associated with noninvasive diarrheal infections.
To confirm our observations in a relevant population, we
performed a series of assays on blood samples obtained from
healthy adult residents of Malawi, an endemic area for iNTS
infections caused by ST313 strains. We expanded our investiga-
tion by using additional ST313 isolates and infected PBMCs with
four strains from lineage 1 and eight strains from lineage 2. In
comparison to the sequence type 19 representative strain STM-4/
74, PBMCs infected with ST313 lineage 1 strains elicited similar
MAIT cell responses, whereas infection with ST313 lineage 2
induced significantly lower levels of MAIT cell responses
(Fig. 3A and SI Appendix, Fig. S2).
Lastly, we extended our findings to a clinically susceptible co-
hort of HIV-infected adults living in Malawi. In comparison with a
cohort of healthy samples from the United Kingdom and Malawi,
and consistent with previous reports (reviewed in ref. 41), the
overall percentage of MAIT cells was reduced among HIV-
infected individuals, particularly in those not receiving anti-
retroviral therapy (ART) (Fig. 3B). In line with the data obtained
with healthy volunteers, MAIT cells from HIV+ adults also failed
to produce IFN-γ and TNF-α following ex vivo stimulation with
STM-D23580, regardless of their ART status (Fig. 3C). In con-
trast, MAIT cells from HIV+ individuals responded strongly to S.
Typhi and STM-4/74.
These findings suggest that evasion of MAIT cell recognition
by sequence type 313 Salmonella strains may be a critical factor
during the course of natural iNTS disease in endemic pop-
ulations and in clinically susceptible groups.
Fig. 1. Identification of cellular responses to multi-
ple S. enterica spp. enterica serovars. PBMCs were
left unstimulated or infected at MOI of 5 with STM-
D23580, STM-LT2, ST-Ty2, or E. coli. Intracellular
staining was performed to detect CD69 expression
and cytokine production (TNF-α and IFN-γ), as cor-
relates of T cell activation. (A) t-SNE plots on gated
CD69+ CD3+ T cells infected with STM-D23580, STM-
LT2, ST-Ty2, or E. coli. Four CD3+ T cell populations
(CD4+, CD8+, γδ+, and MAIT) were annotated based
on the expression of distinct phenotypic markers.
CD4, CD8, TCRγδ, Vα7.2+, CD161, IFN-γ, and TNF-α
were the parameters included for t-SNE analysis.
Plots correspond to one representative donor. (B)
t-SNE plots as in A showing relative expression of
TNF-α and IFN-γ on CD69+ CD3+ T cells. (C) UMAP
analysis on concatenated CD3+ Vα7.2+ CD161+
MAIT cells from the same donor as in A and B. Cal-
culated UMAPs are shown for each experimental
condition. CD69, IFN-γ, and TNF-α were the param-
eters included for analysis. (D, Top Left) UMAP as an
overlay of concatenated MAIT cell populations from
C: unstimulated in light gray, STM-D23580 in blue,
STM-LT2 in green, ST-Ty2 in red, and E. coli in dark
gray. (D, Top Right and Bottom) UMAPs showing
expression of CD69, TNF-α, and IFN-γ in pink. (A–D)
Data from one donor representative of four biological
replicates.
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Fig. 2. S. Typhimurium ST313 lineage 2 fails to elicit MAIT cell activation. PBMCs were left unstimulated (U) or infected with a variety of Salmonella strains at
the indicated MOI. E. coli was included as positive control and E. faecalis as negative control. (A) Production of TNF-α and IFN-γ by MAIT and γδ+ T cells was
detected by intracellular staining. Representative flow cytometry plots from one volunteer are shown. (B) Percentage of TNF-α and/or IFN-γ producing
MAIT cells when stimulated at increasing MOI, from 0.5 to 20 bacteria per cell. Data are represented as mean ± SEM, two-way ANOVA + Dunnet’s, n = 4. (C)
CD69 staining profile of stimulated MAIT and γδ+ T cells. Representative histograms from one volunteer are shown. (D) CD69 expression on MAIT cells when
stimulated as in B. Data are represented as geometric mean ± SEM, two-way ANOVA + Dunnet’s, n = 4. (E) Phylogenetic relationships between strains used in
these experiments (red) within the context of S. enterica phylogeny. (F) Percentage of TNF-α- and/or IFN-γ-producing MAIT cells, treated with bacterial strains
at MOI of 2.5 and 5. Data are represented as mean ± SEM, two-way ANOVA + Dunnet’s, n = 4. (G) Levels of CD69 expression on MAIT cells treated as in E. Data
are represented as geometric mean ± SEM, two-way ANOVA + Dunnet’s, n = 4.
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STM-D23580 Does Not Affect MR1-Dependent Antigen Presentation.
To define the molecular mechanisms underlying the lack of MAIT
stimulation by STM-D23580, we first investigated whether MAIT
cell activation was MR1 dependent. Adding the anti-MR1 blocking
antibody 26.5 (42) completely abrogated the MAIT cell activation
induced by STM-LT2 and E. coli, as well as the minimal activation
induced by STM-D23580 (Fig. 4 A and B).
We next examined whether STM-D23580 either failed to
produce stimulatory MR1 ligands or actively inhibited MAIT cell
activation. MAIT cell activation was restored following the
addition of the canonical MAIT cell ligand 5-amino-6-D-
ribitylaminouracil (5-A-RU) and methylglyoxal (MG) (33) to
infected PBMCs (Fig. 4 C and D), demonstrating that a domi-
nant antagonistic MR1 ligand was not released by STM-D23580.
Consistent with these results, a combination of supernatants
from overnight cultures of both STM-D23580 and STM-LT2
(added simultaneously or 1 h apart) fully restored MAIT cell
activation (SI Appendix, Fig. S3 A and B). Likewise, coinfection
of PBMCs with STM-D23580 plus either STM-LT2, ST-Ty2,
or E. coli, also restored MAIT cell activation to the levels ob-
served with single infections (Fig. 4 E and F). Taken together,
our data show that STM-D23580 neither interferes with nor
blocks MAIT cell activation in the presence of stimulatory MR1
ligands.
To exclude the possibility that the lack of MAIT cell activation
arose from an insufficient infection of APCs, we exposed
monocyte-derived dendritic cells (MoDCs) to fluorescently la-
beled STM-D23580 or STM-LT2. Live Salmonella-containing
MoDCs were sorted by fluorescence-activated cell sorting
(FACS) and cocultured with enriched autologous CD3+ T lym-
phocytes, as described previously (43). In contrast to STM-LT2-
infectedMoDCs, STM-D23580-infectedMoDCs did not stimulate
effector MAIT cells (SI Appendix, Fig. S3C). Using an MR1-
overexpressing antigen-presenting cell line, we found that STM-
D23580 supernatants do not cause down-regulation of surface
MR1 expression, thus excluding this as a possible cause of the lack
of MAIT cell activation (SI Appendix, Fig. S3D).
Cytokines, such as IL-12, IL-18, and type I IFN, released by
APCs upon bacterial or viral infection can also activate
MAIT cells in a MR1-independent manner (31). We confirmed
that when MoDCs were cocultured with purified MAIT cells,
equal amounts of bioactive IL-12p70 were secreted upon infec-
tion with STM-D23580, STM-LT2, and E. coli (SI Appendix,
Fig. S3E).
Taken together, these observations refuted the hypothesis that
lack of MAIT cell activation is caused by an impaired MR1-
dependent antigen presentation following STM-D23580 infection.
STM-D23580 Evades MAIT Cell Recognition by Overexpression of RibB.
The observation that STM-D23580 and related ST313 isolates
do not interfere with MR1 presentation or cytokine production
suggests that these bacteria might not produce the MR1 binding
ligands that are generated by other S. Typhimurium or S. Typhi
pathovariants. The major source of natural antigens driving
MAIT cell activation derives from byproducts of microbial ri-
boflavin synthesis (33). We depict the Salmonella riboflavin
biosynthetic pathway in Fig. 5A. A comparison of the coding
sequences (CDSs) of the enzymes involved in the riboflavin
biosynthesis pathway found only one nucleotide change (SNP)
between the sequence type 19 STM-4/74 and the sequence type
313 STM-D23580 strains. This synonymous coding variant was
located in the ribD gene (Glu316Glu) (44), suggesting that there
were no biochemical differences between the riboflavin biosyn-
thesis pathways of the sequence type 313 and sequence type
19 isolates.
To determine whether the enzymes of the riboflavin pathway
of the sequence type 19 STM-4/74 and sequence type 313 STM-
D23580 strains were expressed at different levels, we investigated
Fig. 3. Characterization of MAIT cell responses to
Salmonella spp. in relevant and susceptible cohorts of
individuals. (A) PBMCs were isolated from 10 healthy
individuals living in Malawi. Cells were infected at
MOI of 7 with various strains from sequence type 313
(ST313) lineages 1 and 2 or with the sequence type 19
(ST19) reference strain STM-4/74. Each dot represents
the average of TNF-α- and/or IFN-γ-producing MAIT
cells per individual upon stimulation with four strains
from lineage 1 and eight strains from lineage 2 (SI
Appendix, Fig. S2). Median ± interquartile range
(IQR), Friedman + Dunn’s, n = 10 for each group. (B)
Percentage of MAIT cells (CD3+ Vα7.2+ CD161+) in
PBMCs isolated from healthy (n = 12) and HIV-
infected individuals living in Malawi, with (n = 6) or
without ART (n = 6). Data are represented as per-
centage of live CD3+ T cells, median with IQR,
Kruskal–Wallis + Dunn’s. (C) PBMCs isolated from
HIV+ patients with or without ART were infected at
MOI of 7 with either STM-D23580, STM-4/74, STy-H58,
or E. coli. Phorbol 12-myristate 13-acetate (PMA)/ion-
omycin was used as positive control. Data are repre-
sented as percentage of TNF-α- and/or IFN-γ-producing
MAIT cells, mean ± SEM, one-way ANOVA + Dunnet’s,
n = 6 for each group. ns = non-significant.
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the transcriptomic and proteomic data from our recent com-
parative analysis (44). Strains STM-4/74 and STM-D23580 are
closely related, sharing 92% of coding genes (44). Differential
gene expression analysis of the rib genes at the transcriptomic
level identified significant up-regulation of ribB (≥2 fold change,
false discovery rate [FDR] ≤ 0.001) in STM-D23580 in four of
the five experimental conditions (Fig. 5B). We then examined
data from a quantitative proteomic approach which showed that
RibB protein levels were up-regulated in STM-D23580 com-
pared to STM-4/74, during growth in rich medium at early sta-
tionary phase (ESP) (Fig. 5C).
We searched for a molecular explanation for the high levels of
ribB expression in STM-D23580 compared to STM-4/74. In
STM-D23580, ribB and its 5′ untranslated region (5′ UTR) are
transcribed as a single transcript that is initiated from a single
gene promoter which we identified previously (44). By analogy
with the genetic mechanism identified for overexpression of the
PgtE virulence factor in STM-D23580 (46) we searched for
nucleotide polymorphisms that distinguished the ribB regions of
the two strains. There were no differences between the promoter
sequences of the ribB genes or the 5′ UTR of the strains STM-
D23580 and STM-4/74.
To determine whether the MAIT cell activation phenotype
was linked to the overexpression of the RibB enzyme
(4-dihydroxy-2-butanone 4-phosphate synthase), we created a
derivative of STM-4/74 that expressed high levels of RibB. Since
deletions in the riboflavin biosynthetic pathway genes are lethal
without high dose riboflavin supplementation (33, 47) and ribB is
essential for Salmonella in vivo virulence (48), we used a gene
cloning approach to overexpress the ribB gene of STM-D23580
in STM-4/74 from a recombinant plasmid (STM-4/74 RibB++).
The expression of high levels of the RibB enzyme by STM-4/74
ablated MAIT cell activation induced by wild-type STM-4/74.
Infection with STM-4/74 RibB++ induced low levels of cytokine
production and CD69 expression by MAIT cells, recapitulating
the phenotype of STM-D23580 (Fig. 5 D and E). Importantly, γδ
Fig. 4. STM-D23580 does not affect MR1-dependent
antigen presentation. (A) PBMCs were infected (at
MOI 2.5 and 7.5) with STM-D23580 (blue), STM-LT2
(green), or E. coli (gray), and incubated in the pres-
ence of anti-MR1 blocking antibody or the equivalent
isotype control. Data are represented as percent-
age of TNF-α- and/or IFN-γ-producing MAIT cells,
box-and-whisker plot, two-way ANOVA + Dunnet’s,
n = 4. (B) Representative example of cytokine pro-
duction by stimulated MAIT cells treated as in A. (C
and D) PBMCs were left unstimulated or infected (at
MOI 2.5 and 5) with either STM-D23580 or STM-LT2, in
the presence (pink bars) or absence (gray bars) of the
MR1 ligands 5-A-RU and MG. Percentage of cytokine-
producing MAIT cells and their CD69 expression are
shown. Data are represented as mean and geometric
mean ± SEM, two-way ANOVA + Bonferroni’s, n = 4.
(E) PBMCs were infected with D23580 at MOI of 2.5,
alone or in combination with STM-LT2 (green), ST-Ty2
(orange), or E. coli (gray), at two different MOI (2.5
and 5). Data are represented as percentage of TNF-
α-and/or IFN-γ-producing MAIT cells, mean ± SEM,
one-way ANOVA + Sidak’s, n = 5. (F) Representative
example of cytokine production by stimulated MAIT
cells treated as in E.
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T cells responded equally to both STM-4/74 wild type and STM-
4/74 RibB++ (SI Appendix, Fig. S4).
We next evaluated the bacterial growth rate, as well as the
infection efficiency of the STM-4/74 RibB++ bacterial strain.
Midlog phase curves demonstrated no significant differences in
the growth rate between STM-4/74 wild type, STM-4/74 RibB++,
and other related strains (SI Appendix, Fig. S5A). Human
monocyte-derived dendritic cells and human monocyte-derived
macrophages were infected in vitro, and the number of intra-
cellular bacterial colony-forming units (cfu) was measured as a
readout of internalization. In both cell types tested, the number
of recovered intracellular STM-4/74 RibB++ was comparable to
Fig. 5. STM-D23580 evades MAIT cell recognition by overexpression of ribB. (A) Schematic representation of Salmonella’s riboflavin pathway, adapted from
Soudais et al. (45). (B) The relative transcriptional expression levels of the ribABDEFH genes were derived from our published RNA-seq dataset (44). The gene
expression values from STM-D23580 and STM-4/74 were determined in five infection-relevant conditions: ESP, anaerobic growth, NonSPI2 (SPI2-noninducing
PCN), InSPI2 (SPI2-inducing PCN), and macrophage (intra-RAW264.7 murine macrophage environment). Values indicate fold change (FC) and FDR, calculated
from a Voom/Limma analysis (using Degust) for the RNA-seq data comparison of STM-D23580 versus STM-4/74. Data represent three biological replicates. (C)
The relative expression levels of the RibABDEFH proteins were derived from our published proteomic dataset for the ESP condition (44). The heat map shows
differential expression analysis following comparison between STM-D23580 and STM-4/74. Results from LC-MS/MS were analyzed using Progenesis QI soft-
ware (Nonlinear Dynamics) for label-free quantification analysis. Each sample represents six biological replicates. Data represented in B and C were extracted
from Canals et al. (44). (D) PBMCs were infected at two different MOI (2 and 5) with STM-D23580 (blue), STM-4/74 (green), or STM-4/74 RibB++ (pink). Data are
represented as percentage of TNF-α- and/or IFN-γ-producing MAIT cells, mean ± SEM, two-way ANOVA + Tukey’s, n = 6. (E) CD69 staining profile of stimulated
MAIT cells treated as in D. Representative histograms from one volunteer are shown. MFI, median fluorescence intensity.
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the number obtained from other Salmonella strains (SI Appendix,
Fig. S5B). These data exclude the possibility that the lack of
MAIT activation by STM-4/74 RibB++ reflects slow growth or
poor bacterial internalization into antigen-presenting cells.
MAIT activator ligands such as 5-OP-RU (5-[2-oxopropyli
deneamino]-6-D-ribitylaminouracil) or 5-OE-RU (5-[2-oxoethyli
deneamino]-6-D-ribitylaminouracil), products of the riboflavin
pathway, cannot be measured due to their unstable nature (33).
Therefore, to investigate whether overexpression of RibB altered
the balance of downstream products from the riboflavin pathway,
we measured the amount of riboflavin, flavin mononucleotide
(FMN), and flavin adenine dinucleotide (FAD) by high perfor-
mance liquid chromatography (HPLC). Following growth to
early stationary phase, intracellular samples and culture super-
natants from STM-4/74 and STM-4/74 RibB++ contained larger
amounts of riboflavin than the sequence type 313 strains STM-
D23580 and STM-D37712 (Fig. 6 A and B). The STM-4/74
RibB++ supernatant with the highest level of riboflavin also
contained the largest amount of FMN, compared with STM-4/
74, STM-D23580, and STM-D37712 (Fig. 6C).
Overall, the data show that the RibB overproducing strain (4/
74 RibB++) produced the highest level of extracellular riboflavin
and FMN, while having the lowest level of intracellular FMN. In
contrast, the STM-4/74 wild-type strain had the largest intra-
cellular amount of FMN, compared with 4/74 RibB++ and both
of the sequence type 313 strains (Fig. 6D). While intracellular
FAD levels were similar between STM-4/74, STM-D23580, and
STM-D37712, STM-4/74 RibB++ contained the lowest level of
intracellular FAD (Fig. 6E). We conclude that the lowest levels
of intracellular FMN was found in the STM-D23580, STM-
D37712, and STM-4/74 RibB++ strains that overexpress the
RibB enzyme.
Reduced MAIT Cell Antibacterial Activity against S. Typhimurium ST313
Lineage 2-Infected Macrophages. To test the role of MAIT cells in
clearing Salmonella infections, we developed an in vitro assay
where human monocyte-derived macrophages were infected with
the different Salmonella strains, either in presence or absence of
purified MAIT cells. As observed with PBMCs, we measured less
IFN-γ in supernatants from cocultures of purified MAIT cells and
macrophages infected with STM-4/74 RibB++ and sequence type
313 lineage 2 strains, as compared to the control sequence type 19
strains (SI Appendix, Fig. S6A).
In these experiments, the number of intracellular colony-
forming units recovered from infected macrophages was used
as a surrogate of bactericidal activity induced by MAIT cells. In
the majority of the biological replicates and in comparison with
macrophages alone, we observed a modest reduction of colony-
forming unit numbers (25% or less) when MAIT cells and se-
quence type 313 lineage 2-infected macrophages were put in
coculture (SI Appendix, Fig. S6B). In contrast, almost all bio-
logical replicates infected with sequence type 19 Salmonella had
a reduction of more than 25% in the number of colony-forming
units when MAIT cells were added to the infected macrophages
(SI Appendix, Fig. S6B). No differences in bactericidal activity
were observed between STM-4/74 RibB++ and STM-4/74. While
macrophages pretreated with IFN-γ acquired bactericidal activity
against all Salmonella isolates (SI Appendix, Fig. S6C), MAIT cell
antimicrobial activity in these in vitro cocultures was not directly
correlated to the amount of IFN-γ found in supernatants (SI
Appendix, Fig. S6D).
Discussion
Here we investigated the ability of MAIT cells to recognize and
respond to diverse invasive S. enterica serovars. We found that
MAIT cells isolated from the blood of healthy individuals were
not activated by exposure to invasive disease-associated S.
Typhimurium sequence type 313 (ST313) lineage 2 strains. Our
data demonstrated how S. Typhimurium ST313 lineage 2 evades
MAIT cell recognition by overexpressing ribB, a bacterial gene
encoding the RibB enzyme involved in the riboflavin pathway.
Our results lead us to propose that this RibB-mediated mecha-
nism provides an evolutionary advantage that allows invasive S.
Typhimurium ST313 lineage 2 bacteria to escape cell immune
responses by overexpressing a single riboflavin bacterial gene.
MR1-restricted MAIT cells are highly abundant in the gut
mucosa (49), where they reach their final maturation upon rec-
ognition of vitamin B2 metabolites derived from gut commensals
presented by MR1 expressing mucosal B cells (49). MAIT cells
show antimicrobial activity in vivo and in vitro (50, 51) through
MR1 dependent and independent interactions. Microorganisms
must express the riboflavin biosynthesis pathway to be able to
activate MAIT cells (29, 52). Mutations in key enzymes of the
riboflavin biosynthetic pathway in both gram-positive and -neg-
ative bacteria can abrogate MAIT cell activation (33, 45). Dif-
ferent bacteria that possess the riboflavin biosynthetic pathway
induce varying levels of MAIT stimulation (36, 37), possibly
Fig. 6. STM-4/74 RibB++ has the lowest intracellular
levels of FMN, a negative regulator of ribB gene
expression. Supernatants from early stationary phase
and bacterial pellets were harvested and analyzed by
HLPC using riboflavin, FMN, and FAD standards. Data
are reported in picomole and have been normalized
to the absorbance (OD600) from each culture. (A)
Riboflavin levels in supernatants. (B) Intracellular
riboflavin levels. (C ) FMN levels in supernatants. (D)
Intracellular FMN levels. (E ) Intracellular FAD levels.
Measurements were obtained from three biological
replicates, mean ± SEM, one-way ANOVA + Dunnet’s.
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through the influences of the microenvironment on bacterial
metabolism and antigen availability, or the known short half-life
of the potent MAIT cell antigens, 5-OP-RU and 5-OE-RU (53).
The ability of MAIT cells to recognize and respond to several
isolates of the same pathogen may also vary to reflect bacterial
metabolic differences. For example, riboflavin metabolism vari-
ation among clinical isolates of Streptococcus pneumoniae pro-
duces different measurable levels of riboflavin and FMN that
correlate with differential activation of MAIT cells (38).
Salmonella spp. possess an active riboflavin biosynthetic path-
way, which generates MAIT cell agonists (29, 33). MAIT cells
recognize and kill S. Typhimurium-infected targets in vitro (32),
and activated MAIT cells accumulate in murine lungs following
intranasal infection with S. Typhimurium (26). However, bacterial
lung clearance was independent of MAIT cells in this infection
model, possibly due to the nonphysiological route of infection.
While some mouse models of infection with Salmonella sequence
type 313 strains have been published (14, 54), these models pre-
sent limited utility as mice have very low frequencies and absolute
numbers of MAIT cells compared with humans (28). Human
studies demonstrated sustained MAIT cell activation and prolif-
eration at the peak of infection with S. Typhi and S. Paratyphi (34,
35). Among immunocompetent humans, the clinical outcomes of
infection by S. enterica spp. depend on the infecting serovar.
Human-restricted typhoidal serovars, such as S. Typhi induce the
most severe form of systemic disease, typhoid fever; while the
broad-host S. Typhimurium sequence type 19 causes self-limiting
gastroenteritis. The recently documented multidrug resistant S.
Typhimurium ST313 clade causes the majority of iNTS cases
among immunocompromised adults and malnourished young
children living in sub-Saharan Africa.
Several bacterial factors have been reported to enhance in-
vasiveness of S. Typhimurium ST313, suggesting a multifactorial
adaptation of this African lineage to a systemic lifestyle. These
include interference with the complement cascade (46), inter-
ference with dendritic cell (DC) function (43), reduced inflam-
masome activation (55), and dissemination through CD11b+
migratory DC (56), among others. In addition, Salmonella is able
to evade the immune system through persistent asymtpomatic
infections (57, 58).
Here we found that S. Typhi, S. Paratyphi A, and most S.
Typhimurium pathovars potently elicited ex vivo MR1-dependent
MAIT cell activation, but all tested isolates from the invasive S.
Typhimurium ST313 lineage 2 barely induced cytokine secretion
or CD69 up-regulation. This suboptimal activation was restricted
to MAIT cells, as γδ cell activation was comparable across all
isolates tested. We excluded differences in infection efficiency,
MR1 expression, costimulatory cytokines (IL-12), the genetic se-
quence of the riboflavin-encoding enzymes of S. Typhimurium,
and the presence of dominant inhibitory ligands as potential
mechanisms for these results. Following comparative proteomic
and transcriptomic analyses, we discovered that invasive S.
Typhimurium ST313 lineage 2 pathovars escape MAIT cell rec-
ognition by overexpressing ribB, a bacterial gene encoding the ri-
boflavin biosynthetic enzyme RibB. By overexpressing this single
riboflavin gene in a sequence type 19 S. Typhimurium strain, we
revealed that up-regulation of this single riboflavin gene was suf-
ficient to abrogate MAIT cell responses.
Transcriptional control of the bacterial ribB gene is controlled
by a conserved FMN riboswitch, which is located in the 5′ UTR
of ribB (59) and is negatively regulated by FMN and other flavins
at the transcriptional and translational levels in E. coli (60). The
SroG small RNA (sRNA) is derived from the ribB 5′ leader
sequence, although the function of this sRNA remains unknown
(61). In addition to the riboswitch-mediated regulation, RibB
expression is induced by growth in a low pH environment (62). In
STM-D23580, both sroG and ribB are transcribed as a single
transcript that is initiated from a single gene promoter which we
identified previously (46).
While the precise molecular mechanism responsible for ribB
overexpression remains to be established, a single noncoding nu-
cleotide polymorphism in the promoter of the pgtE gene of the
ST313 lineage 2 strain STM-D23580 is known to be responsible
for high expression of the outer membrane PgtE virulence factor,
which promotes bacterial survival and dissemination during
mammalian infection (46). The lack of nucleotide differences
between the promoter sequences of the ribB genes or the ribos-
witch of the two strains suggests that the high level of expression of
ribB in STM-D23580 is caused by a novel and uncharacterized
regulatory mechanism.
It has been proposed that genomic changes in ST313 isolates
that confer altered metabolism and increased anaerobic meta-
bolic capacity are linked to adaptation of the extraintestinal
niche (14). Riboflavin and its derivatives are important cofactors
for flavoproteins involved in cellular redox metabolism and
several biochemical pathways, proposed to be essential for the
metabolic adaptation of the ST313 clade. Riboflavin promotes
intracellular microbial survival and virulence during in vivo in-
fection with Histoplasma capsulatum and Brucella abortus (63,
64). In addition, accumulation of riboflavin is a candidate viru-
lence factor in Pseudogymnoascus destructans skin infection (65).
The metabolomic measurements of the end products of the
riboflavin pathway showed a correlation between lower levels of
intracellular FMN and increased expression of RibB. Because
FMN is a negative regulator of ribB gene expression (60), we
speculate that the lower levels of intracellular FMN observed in
the ST313 strains D23580 and D37712 are linked to the high levels
of expression of RibB in these African S. Typhimurium strains.
Overall, our findings suggest that MAIT cells play a crucial role
in defense against invasive Salmonella disease in humans and that
evasion fromMAIT cell recognition is a critical mechanism for the
invasiveness of S. Typhimurium ST313 lineage 2 isolates. We
propose that differences in MAIT cell activation may associate with
distinct diseases caused by closely related microorganisms. The in-
creased susceptibility of immunocompromised patients to the S.
Typhimurium ST313 lineage 2 strains suggests that MAIT cells
might play a particularly relevant role in the context of waning
CD4+ T cell-mediated protective adaptive immunity, where pro-
tection relies mostly on the innate immune response. For example,
following HIV coinfection and/or malnutrition, among individuals
suffering from recurrent gut infections secondary to intestinal bar-
rier dysfunction (66, 67), microbiota dysbiosis (68, 69), and multiple
innate and adaptive immune defects (70). Our findings may be of
major relevance during the initial phase of infection, in the gut,
where it is expected that resident immune cells such as MAIT cells
should prevent systemic infection by encountering and responding
rapidly to bacterial signals. We propose that the ability of MAIT
cells to target gastrointestinal pathogens represents a key immu-
nological evolutionary bottleneck that has been effectively coun-
tered by Salmonella, resulting in the current epidemic of invasive
disease in Africa.
Methods
Bacterial Strains and Preparation of Stocks. This study included representative
strains of S. enterica serovar Typhimurium, from both the sequence type 19
and the sequence type 313. S. Typhi and S. Paratyphi A serovars were utilized
as comparative Typhoidal invasive strains, while E. coli (DH5α) was used as
unrelated bacterial control. SI Appendix, Table S1 lists bacterial strains used
in this study.
Overnight bacterial cultures from a single colony origin were used to
inoculate Luria broth (LB) Lennox broth (Sigma) supplemented with sucrose
(Sigma) at a final concentration of 10%. Inoculated cultures were incubated
at 37 °C under constant shaking for ∼3 h, until reaching midlogarithmic
phase. Bacterial aliquots were prepared and immediately frozen at −80 °C
for long-term storage. Bacterial viability of frozen aliquots was monitored
periodically in order to maintain experimental reproducibility. The number
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of viable colony-forming units was determined with the Miles and Misra
method, by plating 10-fold dilutions of the bacterial suspension onto LB
Lennox agar (Sigma). On the day of the experiment, a single aliquot was
thawed, washed twice with phosphate-buffered saline (PBS), and resus-
pended in RPMI 1640 media to obtain the desired MOI.
In the case of bacterial supernatants, these were taken from late expo-
nential phase cultures, grown from a single colony following 18-h incubation
under constant shaking. Supernatants were filter sterilized before using.
Construction of S. Typhimurium 4/74 pPL-ribB. To construct pPL-ribB, the ribB
gene was amplified from genomic DNA of S. Typhimurium 4/74 using pri-
mers ribB_FW and ribB_RV. The PCR product was used for a linear amplifi-
cation reaction with plasmid pJV300 (pPL) using Phusion DNA polymerase
(New England Biolabs), and the resulting product was digested with DpnI.
The plasmid was transformed into E. coli TOP10 and selected on LB plates
supplemented with 100 μg/mL ampicillin. Plasmid presence was confirmed
by PCR and DNA sequencing using oligonucleotides pPL_Seq_FW and
pPL_Seq_RV. The pPL-ribB plasmid was subsequently purified and trans-
formed into S. Typhimurium 4/74. SI Appendix, Table S2 lists plasmids and
oligonucleotides used in this study.
Isolation of Human Cells from Peripheral Blood from Healthy Volunteers in the
United Kingdom. Leukocyte reduction system cones were obtained from the
UK National Blood Centre with informed consent following local ethical
guidelines (National Health Service Blood and Transplant [NHSTB] account
T293). Blood was diluted in PBS and separated by gradient centrifugation
using Lymphoprep (AxisShield). PBMCs were collected from the interface,
washed with PBS, resuspended in complete medium, and counted. Complete
medium used throughout was RPMI 1640 (Sigma), supplemented with 10%
heat-inactivated fetal calf serum (FCS, Sigma), 2 mM L-glutamine, 1% non-
essential amino acids, and 1% sodium pyruvate (all from Gibco).
Isolation of PBMCs from Healthy and HIV-Infected Volunteers in Malawi. Blood
samples were obtained at Queen Elizabeth Central Hospital (Blantyre,
Malawi) following local ethical guidelines. Samples were deidentified prior to
use. Our study was approved by the Malawi College of Medicine Research
Ethics Committee, Malawi COMREC, P09/17/2284). Adults presenting for HIV
testing at the voluntary testing clinic, the HIV outpatient clinic, and the
medical inpatient wards at the Queen Elizabeth Central Hospital were
recruited. Based on the use of antiretroviral therapy, these patients were
classified as ART naïve (without) or ART treated (with). Upon appropriate
consent and medical authorization, a blood sample was collected and PBMCs
were isolated and used in ex vivo infection assays, as described below.
Ex Vivo Infection Assays with PBMCs. PBMCs were seeded in 96-well round-
bottom plates (5 to 8 × 105 cells per well) and infected with the different
Salmonella strains from frozen midlog phase stocks, at the indicated MOI.
Upon 80-min incubation at 37 °C, 100 μg/mL gentamicin (Lonza) was added
to kill extracellular bacteria. A total of 200 μg/mL of gentamicin was re-
quired for the experiments carried out in Malawi using ST313 strains from
lineages 1 and 2.
At 180 min postinfection, 5 ng/mL brefeldin A (BioLegend) solution was
added to every well in order to achieve accumulation of intracellular cyto-
kines. Samples were incubated overnight at 37 °C for no more than 15 h.
ForMR1 blocking experiments, infection was performed in the presence of
30 μg/mL MR1 blocking antibody 26.5 (42) or mouse IgG2a isotype control
(ATCC). The MAIT agonists 5-A-RU was synthesized as described in ref. 71
and 1 μg/mL was combined to 50 μM MG (Sigma).
Assessment of Cytokine Production and MAIT Cell Activation by Flow Cytometry.
Following incubation in the presence of brefeldin A, cells were harvested,
washed, and stained with a viability dye (live/dead Zombie Aqua, BioLegend)
for 20 min. Fixation was performed for 30 min at 4 °C using the Foxp3 Fixation/
Permeabilization buffers (eBioscience). Fixed cells were permeabilized and
stained with an antibody mixture for 40 min at room temperature, washed,
and stored protected from light at 4 °C in PBS with 0.5% bovine serum al-
bumin (BSA) (FACS buffer) until acquisition. The following antibodies were
used for extracellular and intracellular staining as two different panels: anti-
CD3 Alexa700 (clone UCHT1; BioLegend), anti-CD3 PerCp Cy5.5 (clone UCHT1;
BioLegend), anti-CD4 APCef780 (clone RPA-T4; eBioscience), anti-CD4 Alexa700
(clone RPA-T4; BioLegend), anti-CD8 BV785 (clone RPA-T8; BioLegend), anti-TCR
γ/δ APC (clone B1; BioLegend), anti-CD161 BV605 (clone HP-3G10; BioLegend),
anti-CD161 BV421 (clone HP-3G10; BioLegend), anti-Vα7.2 PE (clone 3C10;
BioLegend), anti-Vα7.2 PE-Cy7 (clone 3C10; BioLegend), anti-CD69 FITC (clone
FN50; BioLegend), anti TNF- α PECy7 (clone Mab11; BioLegend), anti TNF-α APC
(clone Mab11; BioLegend), anti-IFN-γ FITC (clone 4S.B3; BioLegend), and
anti-IFN-γ PE Dazzle (clone 4S.B3; BioLegend). Samples from the United Kingdom
were acquired on a FortessaX20 (BD), while samples from the case-control
study in Malawi were acquired on a LSR Fortessa cytometer (BD). All data
were analyzed with the same gating strategy on FlowJo (v.10.6.1).
Unsupervised Analysis of Flow Cytometry Data. Two dimensionality reduction
methods based on a neighboring graph approach were implemented, t-SNE
(72) and UMAP (73). t-SNE algorithm was performed on the Cytofkit plat-
form (74) using up to 5,000 cells from each sample. UMAP was run as a
plugin on FlowJo (v.10.4.1) using 15 nearest neighbors, a minimum distance
of 0.5, and Euclidean distance for selected parameters. Files with .fcs ex-
tension from related experimental conditions were concatenated before
UMAP analysis.
Coculture of Salmonella-Infected Monocyte-Derived Dendritic Cells and Purified
T Cells.MoDCs were obtained from PBMCs by enrichment of CD14+ monocytes
using magnetic beads (Miltenyi). Differentiation was achieved with recombi-
nant human GM-CSF (40 ng/mL) and human IL-4 (40 ng/mL), both from
PeproTech. After 5 d, MoDCs were infected with violet-labeled (CellTracker,
Life Technologies) Salmonella strains, either STM-D23580 or STM-LT2, at an
MOI of 10, as reported elsewhere (43).
At 6 h postinfection, Salmonella-containing MoDCs were FACS sorted as
single cells. Sorted MoDCs were cocultured with magnetically enriched
(Miltenyi) CD3+ T cells obtained from the same donor, at a ratio of one
MoDC per six T cells. Following 12-h incubation in the presence of brefeldin
A, T cells were harvested and stained for intracellular cytokines as described
above.
Coculture of Salmonella-Infected MoDCs and Expanded MAIT Cells. Human
MoDCs were obtained as described above. Human MAIT cells were isolated
by sorting CD2 MACS-enriched (Miltenyi) leukocytes with CD161 and Vα7.2
antibodies (BioLegend). MAIT cells were grown for around 6 wk in com-
plete RPMI media supplemented with IL-2, as described elsewhere in
ref. 71.
A total of 40,000 MoDCs and 20,000 MAIT cells (2:1 ratio) were seeded in
96-well flat-bottom plates and infected at MOI of 3.5. After 80 min, 100 μg/mL
gentamicin was added and supernatants were harvested following 26-h
incubation. IL-12 p70 was measured by ELISA (R&D Systems) in triplicates
and following manufacturer’s instructions.
Coculture of Salmonella-Infected Monocyte-Derived Macrophages and Expanded
MAIT Cells.Monocyteswereobtained from leukocyte reduction system cones by
enrichment of CD14+ cells using magnetic beads (Miltenyi), according to
manufacturer’s protocol. Monocytes were seeded in 24-well plates (450,000 to
500,000 cells/well) and differentiated into macrophages using recombinant
human M-CSF at 100 ng/mL (PeproTech). After 6 d of incubation at 37 °C and
5% CO2, the adherent macrophages were carefully washed to remove M-CSF-
containing media and fresh antibiotic-free medium was added. Next, macro-
phages were infected with the different Salmonella strains at a MOI of 15.
After 30 min postinfection, cells were washed and incubated for an additional
30 min with 100 μg/mL of gentamicin-containingmedium to kill any remaining
extracellular bacteria. At 1 h postinfection, macrophages were washed again
and MAIT cells were added (ratio of one MAIT cell per five macrophages) into
the respective wells. From this point onwards, media contained gentamicin at
30 μg/mL as a maintenance dose. Cells were incubated until completing 6 h
postinfection before being washed twice with PBS and lysed with 2% saponin.
The number of intracellular viable bacterial cfus was determined with the
Miles and Misra method as described above. IFN-γ in the supernatants was
measured with a commercial ELISA (BD-Pharmingen), as per manufacturer
instructions.
MR1 Overexpressing Cell Line. THP-1 cells were transduced with an MR1-
encoding lentivirus (34). MR1-overexpressing cells were seeded in 96-well
flat-bottom plates and incubated overnight in the presence of 50 μL of
supernatants from bacterial cultures at late exponential phase, or in the
presence of 5-A-RU as positive control. Cells were harvested, washed, and
stained for surface expression of MR1 (clone 26.5; BioLegend) by flow
cytometry. Expression of MHC-I (clone G46-2.6, BD Biosciences) was also
monitored as unrelated control.
Transcriptomic and Proteomic Analyses of Riboflavin Enzymes. RNA sequencing
(RNA-seq) and proteomic data for genes involved in the riboflavin biosyn-
thetic pathway were extracted from recent work (44). Briefly, a differential
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expression comparative analysis between strains STM-D23580 and STM-4/74
was performed at the transcriptomic level in five in vitro infection-relevant
conditions: ESP, anaerobic growth, NonSPI2 (SPI2-noninducing phosphate
carbon nitrogen minimal medium [PCN]), InSPI2 (SPI2-inducing PCN), and
inside murine RAW264.7 macrophages (ATCC, TIB-71). Specific details about
growing bacteria in these conditions had been previously described (40, 75).
For a comparative proteomic analysis, bacteria were grown to ESP in the LB-
rich medium.
The RNA-seq-based comparative approach between STM-D23580 and
STM-4/74 was based on Voom/Limma analysis from three different biological
replicates for each strain. A detailed pipeline for the analysis can be found in
Canals et al. (44).
Proteomic data for strains STM-D23580 and STM-4/74 were obtained using
a liquid chromatography with tandem mass spectrometry (LC-MS/MS, Q
Exactive Orbitrap, 4-h reversed phase C18 gradient) platform. Samples in-
cluded six biological replicates for each strain. Label-free quantification and
differential expression analyses between the two strains were performed
using Progenesis QI software (Nonlinear Dynamics) (44).
Measurement of Riboflavin, FMN, and FAD in Supernatants and Pellets of
Bacterial Cultures. Bacterial pellets and supernatants from early stationary
phase cultures (OD600 = ∼2) were prepared in triplicate and frozen at −80 °C.
For extraction of cellular flavins, pellets were resuspended in 100 μL of
100 mM ammonium formate, 100 mM formic acid, 25% (vol/vol) methanol,
and heated at 80 °C for 10 min. Insoluble material was removed by centri-
fugation. For analysis, 5 μL of this material or the culture supernatants was
separated by HPLC on a Dionex UPLC system with a Kinetex C18 column
(Phenomenex; 1.7 μm, 150 × 2.1 mm). Separation was achieved at 45 °C and
0.2 mL/min isocratically using 20mMpotassium phosphate buffer (pH 2.5) with
25% methanol (vol/vol) over 8 min followed by a 1-min wash step in 100%
methanol. Flavins were detected with fluorescence (450-nm excitation, 520-nm
emission) and peaks were quantified by comparison to known standards. For
normalization the total picomole of flavin for each culture was divided by the
measured OD600 of the cultures to give a final pmol/OD600 value.
Statistical Analysis. Statistical analyses were performed using GraphPad
Prism8 (GraphPad Software). Differences among groups were determined by
paired one-way, two-way ANOVA, or Kruskal–Wallis as appropriate. Post hoc
corrections were applied, Dunnett’s, or Dunn’s for comparisons to a control
dataset, and Bonferroni’s, Tukey’s, or Sidak’s for comparisons of selected
pair tests, as appropriate. A P value <0.05 was considered statistically sig-
nificant (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
Data Availability. All data have been made available in the manuscript.
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